Skip to main content
OpenTrials

Clinical trial condition

SARS-CoV-2

Explore clinical trials studying SARS-CoV-2. Study availability and eligibility vary by location and protocol.

173 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

SARS-CoV-2 trial results

Completed

A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults

NCT05827926

Conditions
Coronaviridae Infections, Coronavirus Infections, Infections, +9 more
Locations
  • Chandler Clinical Trials Chandler, Arizona, United States
  • Benchmark Research Colton, California, United States
  • Marvel Clinical Research Huntington Beach, California, United States
  • Central Valley Research Modesto, California, United States
View all 69 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age

NCT05436834

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Trinity Clinical Research, LLC Bessemer, Alabama, United States
  • Velcocity Clinical Research Banning, California, United States
  • Sera Collection Research Services Montebello, California, United States
  • Center For Clinical Trials LLC -Paramount Paramount, California, United States
View all 74 locations
View Trial Details
Completed

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

NCT05960097

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site Hollywood, Florida, United States
  • GSK Investigational Site Peoria, Illinois, United States
  • GSK Investigational Site Bruce, Australian Capital Territory, Australia
View all 17 locations
View Trial Details
Completed

A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age

NCT06864143

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +13 more
Locations
  • Headlands Research Scottsdale Scottsdale, Arizona, United States
  • Artemis Research (Headlands) San Diego, California, United States
  • Clinical Research Atlanta (Headlands) Stockbridge, Georgia, United States
  • Velocity Clinical Research, Boise Meridian, Idaho, United States
View all 17 locations
View Trial Details
Completed

A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)

NCT06508320

Conditions
Infections, Influenza, Influenza, Human, +6 more
Locations
  • Indago Research & Health Center, Inc. Hialeah, Florida, United States
  • Cenexel RCA Hollywood, Florida, United States
  • Suncoast Research Group, LLC DBA Flourish Research Miami, Florida, United States
  • Cenexel IRA Decatur, Georgia, United States
View all 17 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19

NCT04649151

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Velocity Clinical Research - Banning Banning, California, United States
  • Paradigm Clinical Research La Mesa, California, United States
  • Altus Research - Hunt - PPDS Lake Worth, Florida, United States
  • Accel Research Sites - Nona Pediatric Center - ERN - PPDS Orlando, Florida, United States
View all 53 locations
View Trial Details

Related conditions